Global Wilson’s Disease Market: Industry Analysis & Outlook (2016-2020) - New Report by Koncept Analytics - PowerPoint PPT Presentation

Loading...

PPT – Global Wilson’s Disease Market: Industry Analysis & Outlook (2016-2020) - New Report by Koncept Analytics PowerPoint presentation | free to download - id: 832736-ODg0Z



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Global Wilson’s Disease Market: Industry Analysis & Outlook (2016-2020) - New Report by Koncept Analytics

Description:

This report provides a wide-ranging study of global Wilson’s disease market and also its key regional markets. For more mail: vikas@konceptanalytics.com – PowerPoint PPT presentation

Number of Views:8

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Global Wilson’s Disease Market: Industry Analysis & Outlook (2016-2020) - New Report by Koncept Analytics


1
Global Wilsons Disease Market Industry
Analysis Outlook ------------------------------
---------- (2016-2020)
View Report Details
2
View Report Details
  • Executive Summary
  • Wilsons disease is a rare disease and is named
    after Kinnear Wilson who was the first to
    describe this disorder in 1912. His description
    terms the disease as a progressive lenticular
    degeneration, a hereditary, fatal neurological
    disease that is usually accompanied by chronic
    liver ailment that leads to a condition called
    cirrhosis. Wilson's disease is a hereditary
    disorder that leads to unwarranted accumulation
    of copper in crucial organs such as the liver,
    brain etc. The patient starts to accumulate
    copper from birth but diagnosis tends not to
    occur only in the later ages. The primary signs
    of Wilsons disease become prominent usually
    between the ages of 12 and 23 years.
  • Wilsons disease is caused by the mutation of a
    gene named ATP7B. Absent or reduced function of
    ATP7B protein leads to reduced elimination of
    copper into the bile. Wilsons disease is
    inherited as an autosomal recessive trait, which
    means that in order to develop the disease one
    must inherit two procreations of the defective
    gene, one from each parent. If a person receives
    only one abnormal gene from either of the
    parents, he/she is not likely to get affected by
    the Wilsons disease. Wilsons disease may be
    difficult to primarily diagnose as the symptoms
    are alike to other health issues like heavy metal
    poisoning, hepatitis C, and cerebral palsy.
  • The important factors that are anticipated to
    drive the market include rising prices of
    chelators in the US, rising attractiveness of
    orphan drugs market, increasing global healthcare
    expenditure as well as spending on medicines. The
    noteworthy trends in the market include falling
    number of prescriptions for Wilsons disease, and
    the development of gene therapy as a potential
    cure for the disease. However, the market is
    confronted by crucial challenges such as
    under-diagnosis of the disease, lack of safety in
    treatments, poor compliance to current treatments
    and unmet efficacy needs.
  • This report provides a wide-ranging study of
    global Wilsons disease market and also its key
    regional markets such as the US and Europe.
    Furthermore, market dynamics such as key trends
    and development and challenges are analyzed in
    depth. The global Wilsons disease industry is
    highly competitive consisting of several large
    corporations. The competitive landscape of the
    respective market, along with the company
    profiles of the leading players are also
    discussed in detail.

3
Though it is known that Wilsons disease is a
rare condition, the prevalence of this disease is
limited also because the occurrence of this
condition is highly underdiagnosed
Global Orphan Drugs Market Revenue Actuals
(2012-2015)
  • The global orphan drugs market revenue has been
    growing at a CAGR of xx during the period
    spanning 2012-2015. For the year 2015, the global
    orphan drugs revenue was noted to be US...
    billion which has increased from US.. billion in
    the year 2014.
  • It is noted that the prevalence of Wilsons
    disease is the largest in Europe with nearly
    persons being affected by it in the year 2015,
    followed by the US with . persons affected by
    Wilsons disease.
  • In terms of treatment among newly diagnosed
    patients, it is noted that the market remains
    highly skewed towards D-penicillamine, which
    recorded a share of xx of the total market in
    the year 2015

Wilsons Disease Prevalence by Region (2015)
Wilsons Disease Market by Treatment New
Patients (2015)
4
Europe has the highest prevalence of Wilsons
disease in the world
Europe Wilsons Disease Prevalence Forecast
(2015-2020)
  • The number of persons affected with Wilsons
    disease in Europe in the year 2015, was noted to
    be persons. It is forecasted that the
    prevalence count will reach a sum of .. persons
    by the end of the year 2020.
  • It is noted that in the year 2015, zinc salts
    constituted xx of the total market while
    chelators constituted nearly xx of the total
    market in the same period.
  • The number of Wilsons disease patients treated
    with zinc in the year 2015 is noted to be .
    persons. It is forecasted that the number of
    patients treated with zinc will rise at a CAGR of
    xx over the period 2015-2020, attaining a total
    of . persons by the end of the year 2020.

Europe Wilsons Disease Market by Treatment (2015)
Europe Wilsons Disease Patients Treated with
Zinc - Forecast (2015-2020)
5
Even though the number of prescriptions for
chelators has been declining over the past few
years in the US, the continuing rise in the
prices of chelators is set to make the market
revenue grow over the forthcoming years
The US Wilsons Disease Prevalence Forecast
(2015-2020)
  • The prevalence of Wilsons disease is the second
    largest in the US with nearly persons affected
    by it in the year 2015. It is forecasted that the
    prevalence of this disease will grow rather
    gradually at a CAGR of xx over the forthcoming
    period spanning 2015-2020.
  • It is forecasted that the market revenue of
    copper chelators for Wilsons disease in the US
    will grow at a CAGR of xx over the period
    spanning 2016-2020, attaining total revenue of
    US.... million by the end of 2020.
  • The total number of patients treated with
    chelators in 2015, was recorded to be .. persons
    in the US. It is forecasted that the number of
    patients treated with chelators will attain a sum
    of . persons by the end of 2020.

The US Chelators Market Revenue Forecast
(2016-2020)
The US Wilsons Disease Patients Treated with
Chelators Forecast (2015-2020)
6
Contact Us
View Report Details
These are abridged and sanitized sample pages
from the comprehensive report on the Global
Wilson Disease Market . To know more about this
report or for any customized research
requirement, please contact the following
Koncept Analytics CS-36, Second Floor, Ansal
Plaza Vaishali, Ghaziabad, U.P. 201010 T.
91-120-4130959 C 91-9811715635
vikas_at_konceptanalytics.com
Vikas Gupta BD Manager
www.konceptanalytics.com
About PowerShow.com